speb/financial-data huggingface dataset:
Financial ratios for CAAP — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.77
Shares outstanding: 163222707
Market cap (USD): 941795019.39
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAAP — annual report dated 2022-12-31
Total revenue: 1466662765.9574468
Gross profit: 442218085.106383
Operating income: 304035106.38297874
Net income: 178900000
Capital expenditures: 9423404.25531915
Operating cash flow: 321945744.6808511
Depreciation & amortization: 183489361.70212767
Net tangible assets: -2387135106.382979
Owner earnings: 352965957.4468085
Return on net tangible assets (%): -14.786174293319643
Capex to operating income (%): 3.0994461025987343
Buffett classification: The Great
Stock price: 8.73
P/E ratio: 7.964976143711572
Shares outstanding: 163222707
Book value: 917413829.7872338
P/B ratio: 1.553207708281954
Market cap (USD): 1424934232.1100001
Debt to equity: 1.7095303750482689
Current ratio: 0.9573411363572516
Quick ratio: 0.9340311302802375
Effective tax rate (%): 13.060708174555685
Interest coverage ratio: 1.7395853622906114
COGS to revenue (%): 69.84868673490186
SG&A to revenue (%): 6.646729476311469
Free cash flow (dilution-adjusted): 310786170.212766
Buyback yield (%): 12.843369914490019
Retained earnings: 214035106.38297874
Inventory turnover: 61.083285759594034
Receivables turnover: 8.243472073569595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.04560228316847
FCF margin (%): 21.190022507313248
Rule of 40 score: 21.190022507313248
Financial ratios for CAAP — annual report dated 2023-12-31
Total revenue: 1555597777.7777777
Gross profit: 539290000
Operating income: 464260000
Net income: 266117777.77777776
Capital expenditures: 10441111.11111111
Operating cash flow: 396016666.6666667
Depreciation & amortization: 168436666.66666666
Net tangible assets: -1995538888.8888888
Owner earnings: 424113333.3333333
Return on net tangible assets (%): -21.25307282633207
Capex to operating income (%): 2.248979259706007
Buffett classification: The Great
Stock price: 16.06
P/E ratio: 9.850362859293712
Shares outstanding: 163222707
Book value: 893232222.2222223
P/B ratio: 2.9346866460980032
Market cap (USD): 2621356674.4199996
Debt to equity: 1.675833956330878
Current ratio: 1.0932780116863576
Quick ratio: 1.069736182223207
Effective tax rate (%): -11.987083757775954
Interest coverage ratio: 4.38970426012502
COGS to revenue (%): 65.33229812333666
SG&A to revenue (%): 6.548179406558965
Free cash flow (dilution-adjusted): 382753333.3333333
Buyback yield (%): 0
Retained earnings: 487527777.7777778
Inventory turnover: 56.64336140698539
Receivables turnover: 5.712692033051107
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.629796137880035
FCF margin (%): 24.604903581188513
Revenue growth (%): 6.063766932971365
Rule of 40 score: 30.668670514159878
Financial ratios for CAAP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.46
Shares outstanding: 163222707
Market cap (USD): 2849868464.2200003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAAP — annual report dated 2024-12-31
Total revenue: 1920069791.6666667
Gross profit: 631181250
Operating income: 453439583.3333334
Net income: 320741666.6666667
Capital expenditures: 12701041.666666668
Operating cash flow: 422189583.3333334
Depreciation & amortization: 211466666.6666667
Net tangible assets: -1860597916.6666667
Owner earnings: 519507291.6666667
Return on net tangible assets (%): -27.921523882891584
Capex to operating income (%): 2.801043872989327
Buffett classification: The Great
Stock price: 18.66
P/E ratio: 9.495915339821767
Shares outstanding: 163222707
Book value: 1581208333.333334
P/B ratio: 1.9262077288697983
Market cap (USD): 3045735712.62
Debt to equity: 0.7699728583098365
Current ratio: 1.267974094379938
Quick ratio: 1.249074917595614
Effective tax rate (%): 49.25074003019456
Interest coverage ratio: 4.050677436164669
COGS to revenue (%): 67.12717148410945
SG&A to revenue (%): 6.534267688837265
Free cash flow (dilution-adjusted): 406777083.3333334
Buyback yield (%): 0
Retained earnings: 748448958.3333334
Inventory turnover: 108.44285714285714
Receivables turnover: 8.526616954546716
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.167022573035341
FCF margin (%): 21.18553633304345
Revenue growth (%): 23.429707800788275
Rule of 40 score: 44.61524413383172
Financial ratios for CAAP — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.66
Shares outstanding: 163222707
Market cap (USD): 3045735712.62
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAAP — quarterly report dated 2025-03-31
Total revenue: 486758695.6521739
Gross profit: 170091304.3478261
Operating income: 114784782.60869564
Net income: 44317391.30434782
Capital expenditures: 2414130.4347826084
Operating cash flow: 87258695.6521739
Depreciation & amortization: 64386956.521739125
Net tangible assets: -1965767391.3043478
Owner earnings: 106290217.39130433
Return on net tangible assets (%): -5.407059749870887
Capex to operating income (%): 2.103179864017727
Buffett classification: The Great
Stock price: 18.3
P/E ratio: 16.849906155278134
Shares outstanding: 163222707
Book value: 1716617391.3043475
P/B ratio: 1.7400356964986756
Market cap (USD): 2986975538.1
Debt to equity: 0.7276088971739165
Current ratio: 1.3901009354235447
Quick ratio: 1.366410337185863
Effective tax rate (%): 47.184822521419825
Interest coverage ratio: 4.455216639243977
COGS to revenue (%): 65.05633985235073
SG&A to revenue (%): 7.180818993430367
Free cash flow (dilution-adjusted): 84222826.08695652
Buyback yield (%): 0
Retained earnings: 825307608.6956521
Inventory turnover: 22.393082244427365
Receivables turnover: 1.975211605555776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8246795279878714
FCF margin (%): 17.302788186272103
Rule of 40 score: 17.302788186272103
Financial ratios for CAAP — quarterly report dated 2025-06-30
Total revenue: 560956470.5882353
Gross profit: 195189411.7647059
Operating income: 138988235.29411766
Net income: 60569411.76470588
Capital expenditures: 4569411.764705882
Operating cash flow: 135547058.82352942
Depreciation & amortization: 67677647.05882353
Net tangible assets: -2047857647.0588236
Owner earnings: 123677647.05882353
Return on net tangible assets (%): -6.039367396286162
Capex to operating income (%): 3.2876248518706617
Buffett classification: The Great
Stock price: 20.26
P/E ratio: 31.528199421264283
Shares outstanding: 163222707
Book value: 1849104705.8823533
P/B ratio: 1.7883746838673593
Market cap (USD): 3306892043.82
Debt to equity: 0.7315336706666945
Current ratio: 1.4852339805448431
Quick ratio: 1.4655847661253047
Effective tax rate (%): 16.3623367340308
Interest coverage ratio: 5.267287886218735
COGS to revenue (%): 65.20417857734584
SG&A to revenue (%): 6.890751720276084
Free cash flow (dilution-adjusted): 130418823.52941178
Buyback yield (%): 0
Retained earnings: 946469411.7647059
Inventory turnover: 27.91362901777698
Receivables turnover: 2.025767501933094
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.135205539871566
FCF margin (%): 23.249366103692644
Revenue growth (%): 15.243235631702271
Rule of 40 score: 38.49260173539491
Financial ratios for CAAP — quarterly report dated 2025-09-30
Total revenue: 620320000
Gross profit: 231975294.11764705
Operating income: 175891764.70588237
Net income: 69089411.76470588
Capital expenditures: 5212941.176470588
Operating cash flow: 163523529.4117647
Depreciation & amortization: 59915294.11764706
Net tangible assets: -1934554117.647059
Owner earnings: 123791764.70588236
Return on net tangible assets (%): -6.398981738306015
Capex to operating income (%): 2.9637210048960587
Buffett classification: The Great
Stock price: 18.12
P/E ratio: 16.999998842750355
Shares outstanding: 163222707
Book value: 1767645882.352941
P/B ratio: 1.6731832322111364
Market cap (USD): 2957595450.84
Debt to equity: 0.7522387702088321
Current ratio: 1.5335097294889608
Quick ratio: 1.50876883904294
Effective tax rate (%): 25.622807350836535
Interest coverage ratio: 6.453489877843484
COGS to revenue (%): 62.6039311778361
SG&A to revenue (%): 6.190922332306665
Free cash flow (dilution-adjusted): 157023529.4117647
Buyback yield (%): 0
Retained earnings: 1007357647.0588236
Inventory turnover: 22.174727932285368
Receivables turnover: 2.1373176920769525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.048418114496678
FCF margin (%): 25.313310776980387
Revenue growth (%): 10.582555425292522
Rule of 40 score: 35.89586620227291
Financial ratios for CAAP — annual report dated 2025-12-31
Total revenue: 2308392941.1764708
Gross profit: 811495294.117647
Operating income: 582602352.9411765
Net income: 303198823.5294118
Capital expenditures: 19454117.647058822
Operating cash flow: 547314117.6470588
Depreciation & amortization: 269504705.88235295
Net tangible assets: -1825177647.0588236
Owner earnings: 553249411.7647059
Return on net tangible assets (%): -30.312085656770883
Capex to operating income (%): 3.3391759488865373
Buffett classification: The Great
Stock price: 26
P/E ratio: 13.996724435140598
Shares outstanding: 163222707
Book value: 1953821176.4705882
P/B ratio: 2.172046466230879
Market cap (USD): 4243790382
Debt to equity: 0.6653327295893176
Current ratio: 1.3521250106380933
Quick ratio: 1.3318989065412605
Effective tax rate (%): 22.532929343938058
Interest coverage ratio: 5.452255386614112
COGS to revenue (%): 64.84587698903337
SG&A to revenue (%): 6.692967962432739
Free cash flow (dilution-adjusted): 524025882.35294116
Buyback yield (%): 0
Retained earnings: 1134871764.7058823
Inventory turnover: 86.34971157108924
Receivables turnover: 8.257027673040668
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.311567261972124
FCF margin (%): 22.700896065202475
Revenue growth (%): 20.224428882490265
Rule of 40 score: 42.925324947692744
Financial ratios for CAAP — quarterly report dated 2025-12-31
Total revenue: 661896470.5882353
Gross profit: 220484705.88235295
Operating income: 158072941.17647058
Net income: 138204705.88235295
Capital expenditures: 7058823.529411765
Operating cash flow: 153798823.52941176
Depreciation & amortization: 72222352.94117647
Net tangible assets: -1825177647.0588236
Owner earnings: 203368235.29411766
Return on net tangible assets (%): -11.142380338803443
Capex to operating income (%): 4.46554829490481
Buffett classification: The Great
Stock price: 26
P/E ratio: 13.594009436147344
Shares outstanding: 163222707
Book value: 1953821176.4705882
P/B ratio: 2.172046466230879
Market cap (USD): 4243790382
Debt to equity: 0.6653327295893176
Current ratio: 1.3521250106380933
Quick ratio: 1.3318989065412605
Effective tax rate (%): 12.145982126163855
Interest coverage ratio: 5.632682149744277
COGS to revenue (%): 66.68894371254079
SG&A to revenue (%): 12.00187695960982
Free cash flow (dilution-adjusted): 145424705.88235295
Buyback yield (%): 0
Retained earnings: 1134871764.7058823
Inventory turnover: 25.463182897862232
Receivables turnover: 2.3675767573390787
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.611723464805171
FCF margin (%): 21.970914235743287
Revenue growth (%): 6.702423037824874
Rule of 40 score: 28.673337273568162
Financial ratios for CADL — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 7.82
Shares outstanding: 73270239
Market cap (USD): 572973268.98
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CADL — annual report dated 2022-12-31
Total revenue: 125000
Operating income: -34674000
Net income: -18794000
Capital expenditures: 1297000
Operating cash flow: -31419000
Depreciation & amortization: 778000
Net tangible assets: 47714000
Owner earnings: -19313000
Return on net tangible assets (%): -40.476589680177725
Buffett classification: The Gruesome
Stock price: 1.79
Shares outstanding: 73270239
Book value: 47714000
P/B ratio: 2.748747281929832
Market cap (USD): 131153727.81
Debt to equity: 0.4778471727375613
Current ratio: 12.813000890471951
Quick ratio: 12.813000890471951
Interest coverage ratio: -20.30093676814988
COGS to revenue (%): 0
R&D to revenue (%): 16629.6
SG&A to revenue (%): 11248
Free cash flow (dilution-adjusted): -35023000
Buyback yield (%): 0
Retained earnings: -99089000
Capitalized R&D asset: 20787000
ROCI (R&D-adjusted, %): -22.41581684847571
FCF margin (%): -28018.4
Rule of 40 score: -28018.4
Financial ratios for CADL — annual report dated 2023-12-31
Total revenue: 0
Operating income: -38391000
Net income: -37939000
Capital expenditures: 280000
Operating cash flow: -34244000
Depreciation & amortization: 960000
Net tangible assets: 12745000
Owner earnings: -37259000
Return on net tangible assets (%): -292.34209493919184
Buffett classification: The Gruesome
Stock price: 1.47
Shares outstanding: 73270239
Book value: 12745000
P/B ratio: 8.450941650058846
Market cap (USD): 107707251.33
Debt to equity: 1.7859552765790505
Current ratio: 2.5942611393119006
Quick ratio: 2.5942611393119006
Interest coverage ratio: -14.79421965317919
Free cash flow (dilution-adjusted): -37792000
Buyback yield (%): 0
Retained earnings: -137028000
Capitalized R&D asset: 38433290
ROCI (R&D-adjusted, %): -44.28195301604724
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for CADL — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.93
Shares outstanding: 73270239
Market cap (USD): 507762756.27
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CADL — annual report dated 2024-12-31
Total revenue: 0
Operating income: -33371000
Net income: -55177000
Capital expenditures: 16000
Operating cash flow: -27023000
Depreciation & amortization: 990000
Net tangible assets: 66327000
Owner earnings: -54203000
Return on net tangible assets (%): -81.7208678215508
Buffett classification: The Gruesome
Stock price: 8.68
Shares outstanding: 73270239
Book value: 66327000
P/B ratio: 9.5886392347008
Market cap (USD): 635985674.52
Debt to equity: 0.2030997934476156
Current ratio: 2.7659676516826988
Quick ratio: 2.7659676516826988
Interest coverage ratio: -15.966985645933015
Free cash flow (dilution-adjusted): -32351000
Buyback yield (%): 0
Retained earnings: -192205000
Capitalized R&D asset: 42592730
ROCI (R&D-adjusted, %): -31.79911777386283
Rule of 40 score: 0
Financial ratios for CADL — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.68
Shares outstanding: 73270239
Market cap (USD): 635985674.52
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CADL — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -8130000
Net income: 7379000
Capital expenditures: 3000
Operating cash flow: -8616000
Depreciation & amortization: 245000
Net tangible assets: 74675000
Owner earnings: 7621000
Return on net tangible assets (%): 10.205557415467023
Buffett classification: The Gruesome
Stock price: 5.65
P/E ratio: 14.025506516804446
Shares outstanding: 73270239
Book value: 74675000
P/B ratio: 5.543714099096083
Market cap (USD): 413976850.35
Debt to equity: 0.14613993973886844
Current ratio: 4.641387214111316
Quick ratio: 4.641387214111316
Interest coverage ratio: -26.568627450980394
Free cash flow (dilution-adjusted): -8933000
Buyback yield (%): 0
Retained earnings: -184826000
Capitalized R&D asset: 4016000
ROCI (R&D-adjusted, %): -6.828465995424869
Rule of 40 score: 0
Financial ratios for CADL — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -11177000
Net income: -4796000
Capital expenditures: 31000
Operating cash flow: -8891000
Depreciation & amortization: 242000
Net tangible assets: 90210000
Owner earnings: -4585000
Return on net tangible assets (%): -5.0825850792595055
Buffett classification: The Gruesome
Stock price: 5.06
P/E ratio: 143.53364666666664
Shares outstanding: 73270239
Book value: 90210000
P/B ratio: 4.1098260651812435
Market cap (USD): 370747409.34
Debt to equity: 0.09246203303403171
Current ratio: 7.040978593272171
Quick ratio: 7.040978593272171
Interest coverage ratio: -47.360169491525426
Free cash flow (dilution-adjusted): -9972000
Buyback yield (%): 0
Retained earnings: -189622000
Capitalized R&D asset: 9681720
ROCI (R&D-adjusted, %): -7.7822576810041175
Rule of 40 score: 0
Financial ratios for CADL — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -13207000
Net income: -11269000
Capital expenditures: 117000
Operating cash flow: -10236000
Depreciation & amortization: 195000
Net tangible assets: 80124000
Owner earnings: -11191000
Return on net tangible assets (%): -13.967100993460138
Buffett classification: The Gruesome
Stock price: 5.1
Shares outstanding: 73270239
Book value: 80124000
P/B ratio: 4.6637489254156055
Market cap (USD): 373678218.9
Debt to equity: 0.08994808047526334
Current ratio: 8.247232134687529
Quick ratio: 8.247232134687529
Interest coverage ratio: -82.03105590062111
Free cash flow (dilution-adjusted): -11543000
Buyback yield (%): 0
Retained earnings: -200891000
Capitalized R&D asset: 14470250
ROCI (R&D-adjusted, %): -11.566213794458298
Rule of 40 score: 0
Financial ratios for CADL — annual report dated 2025-12-31
Total revenue: 0
Operating income: -48177000
Net income: -38182000
Capital expenditures: 560000
Operating cash flow: -38311000
Depreciation & amortization: 845000
Net tangible assets: 51922000
Owner earnings: -37897000
Return on net tangible assets (%): -72.98832864681638
Buffett classification: The Gruesome
Stock price: 5.65
Shares outstanding: 73270239
Book value: 51922000
P/B ratio: 7.973052855244405
Market cap (USD): 413976850.35
Debt to equity: 0.9443781056199684
Current ratio: 13.492164054684896
Quick ratio: 13.492164054684896
Interest coverage ratio: -22.735724398301084
Free cash flow (dilution-adjusted): -42715000
Buyback yield (%): 0
Retained earnings: -230387000
Capitalized R&D asset: 51523360
ROCI (R&D-adjusted, %): -25.311623993509237
Rule of 40 score: 0
Financial ratios for CADL — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -15663000
Net income: -29496000
Capital expenditures: 409000
Operating cash flow: -10568000
Depreciation & amortization: 163000
Net tangible assets: 51922000
Owner earnings: -29742000
Return on net tangible assets (%): -57.28207696159624
Buffett classification: The Gruesome
Stock price: 5.65
Shares outstanding: 73270239
Book value: 51922000
P/B ratio: 7.973052855244405
Market cap (USD): 413976850.35
Debt to equity: 0.9443781056199684
Current ratio: 13.492164054684896
Quick ratio: 13.492164054684896
Interest coverage ratio: -11.061440677966102
Free cash flow (dilution-adjusted): -12267000
Buyback yield (%): 0
Retained earnings: -230387000
Capitalized R&D asset: 19003900
ROCI (R&D-adjusted, %): -9.956714119155622
Rule of 40 score: 0
Financial ratios for CBRE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 108.51
Shares outstanding: 292816579
Market cap (USD): 31773526987.29
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBRE — annual report dated 2022-12-31
Total revenue: 30828000000
Gross profit: 6589000000
Operating income: 1327000000
Net income: 1424000000
Capital expenditures: 260000000
Operating cash flow: 1629000000
Depreciation & amortization: 613000000
Net tangible assets: 792000000
Owner earnings: 1777000000
Return on net tangible assets (%): 224.36868686868684
Capex to operating income (%): 19.593067068575735
Buffett classification: The Great
Stock price: 76.96
P/E ratio: 15.825255561685392
Shares outstanding: 292816579
Book value: 8606000000
P/B ratio: 2.6185410085800602
Market cap (USD): 22535163919.839996
Debt to equity: 0.4058796188705554
Current ratio: 1.0348216452317398
Quick ratio: 1.0348216452317398
Effective tax rate (%): 14.11338962605549
COGS to revenue (%): 78.62657324510187
SG&A to revenue (%): 15.081938497469832
Free cash flow (dilution-adjusted): 1209000000
Buyback yield (%): 8.20939224840187
Retained earnings: 8833000000
Receivables turnover: 4.92774936061381
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.814114579088908
FCF margin (%): 3.921759439470611
Rule of 40 score: 3.921759439470611
Financial ratios for CBRE — annual report dated 2023-12-31
Total revenue: 31949000000
Gross profit: 6274000000
Operating income: 1090000000
Net income: 1027000000
Capital expenditures: 305000000
Operating cash flow: 480000000
Depreciation & amortization: 622000000
Net tangible assets: 1057000000
Owner earnings: 1344000000
Return on net tangible assets (%): 127.15231788079471
Capex to operating income (%): 27.981651376146786
Buffett classification: The Good
Stock price: 93.09
P/E ratio: 26.54167024256086
Shares outstanding: 292816579
Book value: 9067000000
P/B ratio: 3.0063191065523327
Market cap (USD): 27258295339.11
Debt to equity: 0.5322598433881107
Current ratio: 1.1726313235472523
Quick ratio: 1.1726313235472523
Effective tax rate (%): 19.57713390759593
COGS to revenue (%): 80.36245265892516
Free cash flow (dilution-adjusted): 79000000
Buyback yield (%): 2.439624311524217
Retained earnings: 9188000000
Receivables turnover: 4.1779782921407085
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.619713386927647
FCF margin (%): 0.24726908510438514
Revenue growth (%): 3.6363046581030236
Rule of 40 score: 3.8835737432074087
Financial ratios for CBRE — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 178000000
Buffett classification: The Gruesome
Stock price: 124.48
Shares outstanding: 292816579
Market cap (USD): 36449807753.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBRE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 131.29
Shares outstanding: 292816579
Market cap (USD): 38443888656.909996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBRE — annual report dated 2024-12-31
Total revenue: 35767000000
Gross profit: 6956000000
Operating income: 1271000000
Net income: 1036000000
Capital expenditures: 307000000
Operating cash flow: 1708000000
Depreciation & amortization: 674000000
Net tangible assets: 492000000
Owner earnings: 1403000000
Return on net tangible assets (%): 285.1626016260162
Capex to operating income (%): 24.154209284028326
Buffett classification: The Great
Stock price: 131.29
P/E ratio: 37.10800063408301
Shares outstanding: 292816579
Book value: 9192000000
P/B ratio: 4.1823203499684505
Market cap (USD): 38443888656.909996
Debt to equity: 0.6194516971279374
Current ratio: 1.0735436631850974
Quick ratio: 1.0735436631850974
Effective tax rate (%): 14.942528735632186
COGS to revenue (%): 80.55190538764782
Free cash flow (dilution-adjusted): 1255000000
Buyback yield (%): 1.630948433951677
Retained earnings: 9567000000
Receivables turnover: 4.417860671936759
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.41944886062533
FCF margin (%): 3.508820980233176
Revenue growth (%): 11.9502957839056
Rule of 40 score: 15.459116764138777
Financial ratios for CBRE — quarterly report dated 2025-03-31
Total revenue: 8875000000
Gross profit: 1610000000
Operating income: 276000000
Net income: 191000000
Capital expenditures: 64000000
Operating cash flow: -546000000
Depreciation & amortization: 142000000
Net tangible assets: -475000000
Owner earnings: 269000000
Return on net tangible assets (%): -56.631578947368425
Capex to operating income (%): 23.18840579710145
Buffett classification: The Great
Stock price: 130.78
P/E ratio: 50.12375942620419
Shares outstanding: 292816579
Book value: 9004000000
P/B ratio: 4.25305999573745
Market cap (USD): 38294552201.62
Debt to equity: 0.9843402932030209
Current ratio: 0.9965955097534045
Quick ratio: 0.9965955097534045
Effective tax rate (%): 21.39917695473251
COGS to revenue (%): 81.85915492957746
Free cash flow (dilution-adjusted): -631000000
Buyback yield (%): 1.0915390727099743
Retained earnings: 9386000000
Receivables turnover: 1.0491783898806006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.780874951606659
FCF margin (%): -7.109859154929578
Rule of 40 score: -7.109859154929578
Financial ratios for CBRE — quarterly report dated 2025-06-30
Total revenue: 9754000000
Gross profit: 1812000000
Operating income: 355000000
Net income: 239000000
Capital expenditures: 74000000
Operating cash flow: 57000000
Depreciation & amortization: 320000000
Net tangible assets: -642000000
Owner earnings: 485000000
Return on net tangible assets (%): -75.54517133956386
Capex to operating income (%): 20.845070422535212
Buffett classification: The Great
Stock price: 140.12
P/E ratio: 95.41734662669768
Shares outstanding: 292816579
Book value: 8993000000
P/B ratio: 4.562377298952518
Market cap (USD): 41029459049.48
Debt to equity: 1.0608250861781385
Current ratio: 1.1258589852207475
Quick ratio: 1.1258589852207475
Effective tax rate (%): 20.333333333333332
COGS to revenue (%): 81.42300594627845
Free cash flow (dilution-adjusted): -59000000
Buyback yield (%): 0.6385655723221643
Retained earnings: 9393000000
Receivables turnover: 1.0316234796404018
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0796719390743994
FCF margin (%): -0.6048800492105804
Revenue growth (%): 9.904225352112677
Rule of 40 score: 9.299345302902097
Financial ratios for CBRE — quarterly report dated 2025-09-30
Total revenue: 10258000000
Gross profit: 1954000000
Operating income: 445000000
Net income: 396000000
Capital expenditures: 84000000
Operating cash flow: 827000000
Depreciation & amortization: 230000000
Net tangible assets: -295000000
Owner earnings: 542000000
Return on net tangible assets (%): -183.72881355932202
Capex to operating income (%): 18.876404494382022
Buffett classification: The Great
Stock price: 157.56
P/E ratio: 55.854939693995156
Shares outstanding: 292816579
Book value: 9293000000
P/B ratio: 4.9646163980673625
Market cap (USD): 46136180187.24
Debt to equity: 1.0202302808565586
Current ratio: 1.1274210903873745
Quick ratio: 1.1274210903873745
Effective tax rate (%): 18.68583162217659
COGS to revenue (%): 80.95145252485865
Free cash flow (dilution-adjusted): 696000000
Buyback yield (%): 0
Retained earnings: 9768000000
Receivables turnover: 1.0441775244299674
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5554151831859424
FCF margin (%): 6.7849483330083835
Revenue growth (%): 5.167110928849702
Rule of 40 score: 11.952059261858086
Financial ratios for CBRE — quarterly report dated 2025-12-31
Total revenue: 11629000000
Gross profit: 2156000000
Operating income: 218000000
Net income: 450000000
Capital expenditures: 144000000
Operating cash flow: 1221000000
Depreciation & amortization: 189000000
Net tangible assets: -1145000000
Owner earnings: 495000000
Return on net tangible assets (%): -43.23144104803494
Capex to operating income (%): 66.05504587155964
Buffett classification: The Good
Stock price: 160.79
P/E ratio: 36.8981016750862
Shares outstanding: 292816579
Book value: 9626000000
P/B ratio: 4.891125881717223
Market cap (USD): 47081977737.409996
Debt to equity: 1.0379181383752338
Current ratio: 1.0948863636363637
Quick ratio: 1.0948863636363637
Effective tax rate (%): 20.212765957446805
COGS to revenue (%): 82.76721988133116
Free cash flow (dilution-adjusted): 1067000000
Buyback yield (%): 0.6116990276115003
Retained earnings: 9916000000
Receivables turnover: 1.102170410387641
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1747588511073987
FCF margin (%): 9.175337518273283
Revenue growth (%): 13.365178397348412
Rule of 40 score: 22.540515915621697
Financial ratios for CBRE — annual report dated 2025-12-31
Total revenue: 40550000000
Gross profit: 7566000000
Operating income: 1294000000
Net income: 1277000000
Capital expenditures: 366000000
Operating cash flow: 1559000000
Depreciation & amortization: 729000000
Net tangible assets: -1145000000
Owner earnings: 1640000000
Return on net tangible assets (%): -143.23144104803492
Capex to operating income (%): 28.284389489953632
Buffett classification: The Good
Stock price: 160.79
P/E ratio: 36.86920731198904
Shares outstanding: 292816579
Book value: 9626000000
P/B ratio: 4.891125881717223
Market cap (USD): 47081977737.409996
Debt to equity: 1.0379181383752338
Current ratio: 1.0948863636363637
Quick ratio: 1.0948863636363637
Effective tax rate (%): 19.8870765370138
COGS to revenue (%): 81.3415536374846
Free cash flow (dilution-adjusted): 1073000000
Buyback yield (%): 2.055988398360876
Retained earnings: 9916000000
Receivables turnover: 3.8432376078096864
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.973109877674193
FCF margin (%): 2.6461159062885327
Revenue growth (%): 13.372661950960381
Rule of 40 score: 16.018777857248914
Financial ratios for CEK.DE — annual report dated 2022-05-31
Total revenue: 31316129.032258064
Gross profit: 15367741.935483871
Operating income: 3866666.6666666665
Net income: 2694623.6559139783
Capital expenditures: 811827.9569892472
Operating cash flow: 1118279.569892473
Depreciation & amortization: 1304301.0752688171
Net tangible assets: 10903225.806451613
Owner earnings: 3187096.774193548
Return on net tangible assets (%): 29.230769230769226
Capex to operating income (%): 20.99555061179088
Buffett classification: The Great
Stock price: 5.193548387096774
P/E ratio: 15.380446927374303
Shares outstanding: 7980000
Book value: 16893548.387096774
P/B ratio: 2.4532747756349056
Market cap (USD): 41444516.129032254
Debt to equity: 0.45280376806059447
Current ratio: 8.882647385984427
Quick ratio: 2.638487208008898
Effective tax rate (%): 27.25689404934688
Interest coverage ratio: 21.53293413173653
COGS to revenue (%): 50.92707045735476
R&D to revenue (%): 12.357505837110287
SG&A to revenue (%): 25.284988325779423
Free cash flow (dilution-adjusted): -274193.5483870968
Buyback yield (%): 0
Retained earnings: 7853763.440860215
Inventory turnover: 1.3211009174311927
Receivables turnover: 12.201089233347298
Capitalized R&D asset: 3869892.4731182796
ROCI (R&D-adjusted, %): 19.622732083046944
FCF margin (%): -0.8755665430572724
Rule of 40 score: -0.8755665430572724
Financial ratios for CEK.DE — annual report dated 2023-05-31
Total revenue: 32345161.29032258
Gross profit: 15577419.354838708
Operating income: 4215053.76344086
Net income: 2719354.838709677
Capital expenditures: 874193.5483870967
Operating cash flow: 5021505.376344086
Depreciation & amortization: 1494623.6559139783
Net tangible assets: 12851612.903225806
Owner earnings: 3339784.9462365587
Return on net tangible assets (%): 25.98728246318608
Capex to operating income (%): 20.739795918367346
Buffett classification: The Great
Stock price: 4.053763440860215
P/E ratio: 11.89584816132859
Shares outstanding: 7980000
Book value: 18538709.677419353
P/B ratio: 1.7449451887941536
Market cap (USD): 32349032.258064516
Debt to equity: 0.3651760338727452
Current ratio: 7.532579185520362
Quick ratio: 1.968325791855204
Effective tax rate (%): 30.022136137244047
Interest coverage ratio: 14.904942965779469
COGS to revenue (%): 51.840031913832654
R&D to revenue (%): 12.70237026694591
SG&A to revenue (%): 25.118845783052425
Free cash flow (dilution-adjusted): 3574193.5483870967
Buyback yield (%): 0
Retained earnings: 9508602.150537634
Inventory turnover: 1.2681141741888264
Receivables turnover: 20.533105802047782
Capitalized R&D asset: 6701430.107526882
ROCI (R&D-adjusted, %): 15.777914693428919
Rosenberg metric: 0.05418171714365067
FCF margin (%): 11.050164555699611
Revenue growth (%): 3.2859497321796454
Rule of 40 score: 14.336114287879257
Financial ratios for CEK.DE — annual report dated 2024-05-31
Total revenue: 32208695.65217391
Gross profit: 15058695.652173912
Operating income: 2858695.652173913
Net income: 1358695.652173913
Capital expenditures: 850000
Operating cash flow: -13173913.04347826
Depreciation & amortization: 1496739.1304347825
Net tangible assets: 15948913.04347826
Owner earnings: 2005434.7826086953
Return on net tangible assets (%): 12.574115722756082
Capex to operating income (%): 29.733840304182507
Buffett classification: The Good
Stock price: 6.467391304347826
P/E ratio: 37.9848
Shares outstanding: 7980000
Book value: 21625000
P/B ratio: 2.3865795425986427
Market cap (USD): 51609782.608695656
Debt to equity: 0.923146519225936
Current ratio: 10.901864227928245
Quick ratio: 3.2708406612733034
Effective tax rate (%): 35.23316062176166
Interest coverage ratio: 4.495726495726497
COGS to revenue (%): 53.24649028077755
R&D to revenue (%): 12.290766738660908
SG&A to revenue (%): 26.50850431965443
Free cash flow (dilution-adjusted): -14789130.434782607
Buyback yield (%): 0
Retained earnings: 9894565.217391305
Inventory turnover: 0.727264346623646
Receivables turnover: 3.6380601596071207
Capitalized R&D asset: 7988523.6091631595
ROCI (R&D-adjusted, %): 5.403380749304378
Rosenberg metric: -0.12625308648999228
FCF margin (%): -45.91657667386609
Revenue growth (%): -0.42190433655218346
Rule of 40 score: -46.33848101041827
Financial ratios for CEK.DE — quarterly report dated 2024-11-30
Capital expenditures: 0
Net tangible assets: 20320000
Buffett classification: The Gruesome
Stock price: 6.6421052631578945
Shares outstanding: 7980000
Book value: 25501052.63157895
P/B ratio: 2.0785024353999835
Market cap (USD): 53004000
Debt to equity: 0.8227936927268225
Current ratio: 8.586477987421384
Quick ratio: 3.575696316262354
Buyback yield (%): 0
Retained earnings: 9275789.47368421
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEK.DE — annual report dated 2025-05-31
Total revenue: 63403409.09090909
Gross profit: 25901136.363636363
Operating income: 9668181.818181818
Net income: 5385227.2727272725
Capital expenditures: 2026136.3636363635
Operating cash flow: 16842045.454545453
Depreciation & amortization: 1839772.7272727273
Net tangible assets: 27487500
Owner earnings: 5198863.636363637
Return on net tangible assets (%): 18.913555748480714
Capex to operating income (%): 20.956746591443345
Buffett classification: The Great
Stock price: 16.181818181818183
P/E ratio: 23.97872968980798
Shares outstanding: 7980000
Book value: 32225000
P/B ratio: 4.007165526482828
Market cap (USD): 129130909.09090911
Debt to equity: 0.24807814373369066
Current ratio: 15.101368474404461
Quick ratio: 5.613786112519007
Effective tax rate (%): 31.665465032444125
Interest coverage ratio: 9.701254275940707
COGS to revenue (%): 59.14866923559459
R&D to revenue (%): 8.95241509095797
SG&A to revenue (%): 17.221973295098124
Free cash flow (dilution-adjusted): 14387500
Buyback yield (%): 0
Retained earnings: 14492045.454545455
Inventory turnover: 1.7630215289278273
Receivables turnover: 10.531332578331446
Capitalized R&D asset: 9684301.160270303
ROCI (R&D-adjusted, %): 19.26914796875206
Rosenberg metric: 2.7388922170635515
FCF margin (%): 22.69199749081459
Revenue growth (%): 96.85183708030632
Rule of 40 score: 119.54383457112091
Financial ratios for CEK.DE — quarterly report dated 2025-05-31
Capital expenditures: 0
Net tangible assets: 27487500
Buffett classification: The Gruesome
Stock price: 16.181818181818183
Shares outstanding: 7980000
Book value: 32225000
P/B ratio: 4.007165526482828
Market cap (USD): 129130909.09090911
Debt to equity: 0.24807814373369066
Current ratio: 15.101368474404461
Quick ratio: 5.613786112519007
Buyback yield (%): 0
Retained earnings: 14492045.454545455
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COSMOFIRST.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.008439931425556
Shares outstanding: 25958155
Market cap (USD): 389591410.04813397
Buyback yield (%): 0.17940124015891418
Retained earnings: 122158776.2099433
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COSMOFIRST.NS — annual report dated 2023-03-31
Total revenue: 368481120.5846529
Gross profit: 104572472.59439708
Operating income: 37896467.72228989
Net income: 29718635.80998782
Capital expenditures: 46265529.84165652
Operating cash flow: 56657734.470158346
Depreciation & amortization: 9013398.294762485
Net tangible assets: 157334957.36906213
Owner earnings: -7533495.736906216
Return on net tangible assets (%): -4.788189390889669
Capex to operating income (%): 122.08401632758013
Buffett classification: The Gruesome
Stock price: 7.0455542021924495
P/E ratio: 6.154037123734581
Shares outstanding: 25958155
Book value: 158112058.46528625
P/B ratio: 1.1567086648332179
Market cap (USD): 182889588.04141295
Debt to equity: 0.7179801247977813
Current ratio: 1.3256050498100338
Quick ratio: 0.7921739910850509
Effective tax rate (%): 19.711079666984766
Interest coverage ratio: 7.9147799542101245
COGS to revenue (%): 71.62067016392142
SG&A to revenue (%): 1.4279905990618895
Free cash flow (dilution-adjusted): 9538367.84409257
Buyback yield (%): 9.646202559004017
Retained earnings: 142604141.2911084
Inventory turnover: 4.0504178116762946
Receivables turnover: 15.159500901984366
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.640998371810676
FCF margin (%): 2.588563514179087
Rule of 40 score: 2.588563514179087
Financial ratios for COSMOFIRST.NS — annual report dated 2024-03-31
Total revenue: 304145581.00491667
Gross profit: 81147619.61865932
Operating income: 11909101.810768677
Net income: 7457728.744453771
Capital expenditures: 35256025.902386375
Operating cash flow: 29406403.645521045
Depreciation & amortization: 10809449.574289484
Net tangible assets: 159618659.31166807
Owner earnings: -16988847.58364312
Return on net tangible assets (%): -10.643396991871139
Capex to operating income (%): 296.04269459268954
Buffett classification: The Gruesome
Stock price: 5.964131477927063
P/E ratio: 20.75938327195744
Shares outstanding: 25958155
Book value: 161591317.90382537
P/B ratio: 0.9580827197445907
Market cap (USD): 154817849.3444098
Debt to equity: 0.7777678829841709
Current ratio: 1.1878256383801906
Quick ratio: 0.7490241595735532
Effective tax rate (%): 14.090343970161626
Interest coverage ratio: 1.19133877159309
COGS to revenue (%): 73.31948097008599
SG&A to revenue (%): 2.000575648491683
Free cash flow (dilution-adjusted): -7042810.888595754
Buyback yield (%): 0.21688175923039765
Retained earnings: 146373665.9071831
Inventory turnover: 3.6435919039128475
Receivables turnover: 9.699671102952426
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.199580507112772
FCF margin (%): -2.3156051997618547
Revenue growth (%): -17.459656950037996
Rule of 40 score: -19.77526214979985
Financial ratios for COSMOFIRST.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 168473483.03870043
Buffett classification: The Gruesome
Stock price: 9.369087434304825
Shares outstanding: 25958155
Book value: 170573339.7037745
P/B ratio: 1.4258044325719164
Market cap (USD): 243204223.82823697
Debt to equity: 0.8287442928769502
Current ratio: 1.3352023798792032
Quick ratio: 0.8531957090056792
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COSMOFIRST.NS — annual report dated 2025-03-31
Total revenue: 328394902.969371
Gross profit: 93557400.04676174
Operating income: 22791676.408697683
Net income: 15591536.123451017
Capital expenditures: 57486555.99719429
Operating cash flow: 19449380.406827215
Depreciation & amortization: 11655365.910685059
Net tangible assets: 169238952.53682485
Owner earnings: -30239653.963058215
Return on net tangible assets (%): -17.86802240842181
Capex to operating income (%): 252.22609766105867
Buffett classification: The Gruesome
Stock price: 7.155093943283931
P/E ratio: 11.912427111012299
Shares outstanding: 25958155
Book value: 171432078.5597381
P/B ratio: 1.0834205545411035
Market cap (USD): 185733037.6193255
Debt to equity: 0.9807287084961439
Current ratio: 1.276917276949362
Quick ratio: 0.7923782175199929
Effective tax rate (%): 18.248130440112785
Interest coverage ratio: 2.118439639248071
COGS to revenue (%): 71.51070275427274
SG&A to revenue (%): 1.698414789131
Free cash flow (dilution-adjusted): -39989478.60649988
Buyback yield (%): 1.1984185881339628
Retained earnings: 151152677.1101239
Inventory turnover: 3.3254424156140843
Receivables turnover: 8.976162326250199
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.773936881751438
FCF margin (%): -12.17725313179713
Revenue growth (%): 7.972932529327904
Rule of 40 score: -4.204320602469226
Financial ratios for COSMOFIRST.NS — quarterly report dated 2025-03-31
Total revenue: 87194295.06663549
Gross profit: 30399812.95300444
Operating income: 5274725.274725274
Net income: 3168108.4872574233
Capital expenditures: 0
Depreciation & amortization: 3059387.4210895486
Net tangible assets: 169238952.53682485
Owner earnings: 6227495.9083469715
Return on net tangible assets (%): 3.679706010347662
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.155093943283931
P/E ratio: 14.656461289628323
Shares outstanding: 25958155
Book value: 171432078.5597381
P/B ratio: 1.0834205545411035
Market cap (USD): 185733037.6193255
Debt to equity: 0.9807287084961439
Current ratio: 1.276917276949362
Quick ratio: 0.7923782175199929
Effective tax rate (%): 16.82013505217925
Interest coverage ratio: 1.698155814828754
COGS to revenue (%): 65.13554822620867
Buyback yield (%): 0
Retained earnings: 151152677.1101239
Inventory turnover: 0.8042445411955568
Receivables turnover: 2.383320019172392
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.5677063608156798
Rule of 40 score: 0
Financial ratios for COSMOFIRST.NS — quarterly report dated 2025-06-30
Total revenue: 93614556.5176691
Gross profit: 34216007.48888369
Operating income: 7415164.989468758
Net income: 5016381.933068102
Capital expenditures: 0
Depreciation & amortization: 3530306.576175989
Owner earnings: 8546688.509244092
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.569857243154694
P/E ratio: 17.55490622253324
Shares outstanding: 25958155
Market cap (USD): 352248457.6456822
Effective tax rate (%): 21.281674623576937
Interest coverage ratio: 1.9984232103437403
COGS to revenue (%): 63.450120620476724
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 7.363166874767581
Rule of 40 score: 7.363166874767581
Financial ratios for COSMOFIRST.NS — quarterly report dated 2025-09-30
Total revenue: 103611048.47801578
Gross profit: 37129650.50732807
Operating income: 7838782.412626832
Net income: 5263810.597519729
Capital expenditures: 0
Depreciation & amortization: 3886133.0326944757
Net tangible assets: 171422773.3934611
Owner earnings: 9149943.630214205
Return on net tangible assets (%): 5.337647646857654
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.560879368658398
P/E ratio: 18.4545830925862
Shares outstanding: 25958155
Book value: 173674182.638106
P/B ratio: 1.4290137130231289
Market cap (USD): 248182788.58793685
Debt to equity: 1.1097897422248764
Current ratio: 1.1904112519386065
Quick ratio: 0.7034266538317558
Effective tax rate (%): 18.530797417553657
Interest coverage ratio: 1.896100354513226
COGS to revenue (%): 64.1643907162987
Buyback yield (%): 0
Inventory turnover: 0.809468901426238
Receivables turnover: 2.9059318282425854
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3027753858382463
Revenue growth (%): 10.678352098436653
Rule of 40 score: 10.678352098436653
Financial ratios for COSMOFIRST.NS — quarterly report dated 2025-12-31
Total revenue: 100142586.61022614
Gross profit: 32253536.816308346
Operating income: 3679402.9185696784
Net income: 3286175.7825554195
Capital expenditures: 0
Depreciation & amortization: 3944524.896958895
Owner earnings: 7230700.679514315
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.657346552300323
P/E ratio: 11.877908766682697
Shares outstanding: 25958155
Market cap (USD): 198770588.6933274
Effective tax rate (%): 4.930712213986464
Interest coverage ratio: 0.8939106901217863
COGS to revenue (%): 67.79238692740661
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -3.347579161430434
Rule of 40 score: -3.347579161430434
Financial ratios for CPRX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.77
Shares outstanding: 122417458
Market cap (USD): 828766190.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPRX — annual report dated 2022-12-31
Total revenue: 214203000
Gross profit: 179810000
Operating income: 101838000
Net income: 83079000
Capital expenditures: 29000
Operating cash flow: 116047000
Depreciation & amortization: 1239000
Net tangible assets: 267950000
Owner earnings: 84289000
Return on net tangible assets (%): 31.456988244075383
Capex to operating income (%): 0.028476600090339556
Buffett classification: The Great
Stock price: 18.6
P/E ratio: 27.407223471635433
Shares outstanding: 122417458
Book value: 300421000
P/B ratio: 7.579246187183985
Market cap (USD): 2276964718.8
Debt to equity: 0.012961810259602358
Current ratio: 5.570709175522678
Quick ratio: 5.452542196290894
Effective tax rate (%): 20.664826822257663
COGS to revenue (%): 16.056264384719167
R&D to revenue (%): 9.238432701689518
SG&A to revenue (%): 26.649953548736477
Free cash flow (dilution-adjusted): 108111000
Buyback yield (%): 0
Retained earnings: 49862000
Inventory turnover: 5.0540778839088905
Receivables turnover: 19.846474566848883
Capitalized R&D asset: 19789000
ROCI (R&D-adjusted, %): 34.04976650060731
FCF margin (%): 50.47128191481912
Rule of 40 score: 50.47128191481912
Financial ratios for CPRX — annual report dated 2023-12-31
Total revenue: 398204000
Gross profit: 346237000
Operating income: 86812000
Net income: 71410000
Capital expenditures: 231000
Operating cash flow: 143600000
Depreciation & amortization: 32881000
Net tangible assets: 193832000
Owner earnings: 104060000
Return on net tangible assets (%): 53.685665937512894
Capex to operating income (%): 0.26609224531170805
Buffett classification: The Great
Stock price: 16.81
P/E ratio: 28.817217042150954
Shares outstanding: 122417458
Book value: 387881000
P/B ratio: 5.305331967742684
Market cap (USD): 2057837468.9799998
Debt to equity: 0.009170338325414237
Current ratio: 2.8835176104019036
Quick ratio: 2.677845996082195
Effective tax rate (%): 24.442657468442828
COGS to revenue (%): 13.050346053781478
R&D to revenue (%): 23.392532470793864
SG&A to revenue (%): 33.57826641620878
Free cash flow (dilution-adjusted): 47606000
Buyback yield (%): 0
Retained earnings: 121272000
Inventory turnover: 3.321848632063411
Receivables turnover: 7.42197867740252
Capitalized R&D asset: 106408630
ROCI (R&D-adjusted, %): 28.436992343751417
Rosenberg metric: 8.41007630501794
FCF margin (%): 11.95517875259917
Revenue growth (%): 85.90029084559974
Rule of 40 score: 97.85546959819891
Financial ratios for CPRX — quarterly report dated 2024-09-30
Capital expenditures: 259000
Buffett classification: The Gruesome
Stock price: 19.88
Shares outstanding: 122417458
Market cap (USD): 2433659065.04
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CPRX — annual report dated 2024-12-31
Total revenue: 491734000
Gross profit: 422889000
Operating income: 195124000
Net income: 163889000
Capital expenditures: 556000
Operating cash flow: 239808000
Depreciation & amortization: 37774000
Net tangible assets: 570960000
Owner earnings: 201107000
Return on net tangible assets (%): 35.22260753818131
Capex to operating income (%): 0.28494700805641543
Buffett classification: The Great
Stock price: 20.87
P/E ratio: 15.588919015065077
Shares outstanding: 122417458
Book value: 727632000
P/B ratio: 3.5111874525309497
Market cap (USD): 2554852348.46
Debt to equity: 0.0043813356202036195
Current ratio: 5.16754503720645
Quick ratio: 5.005618256848805
Effective tax rate (%): 24.21773488761369
COGS to revenue (%): 14.000455530835776
R&D to revenue (%): 2.5721223262983646
SG&A to revenue (%): 36.14555837098919
Free cash flow (dilution-adjusted): 217001000
Buyback yield (%): 0
Retained earnings: 285161000
Inventory turnover: 3.523105265851287
Receivables turnover: 7.449160758649943
Capitalized R&D asset: 81588870
ROCI (R&D-adjusted, %): 20.42412900525092
Rosenberg metric: 0.8228878153515835
FCF margin (%): 44.12975307788357
Revenue growth (%): 23.48796094464144
Rule of 40 score: 67.617714022525
Financial ratios for CPRX — quarterly report dated 2024-12-31
Capital expenditures: 88000
Buffett classification: The Gruesome
Stock price: 20.87
Shares outstanding: 122417458
Market cap (USD): 2554852348.46
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0